India · Delayed Price · Currency is INR Anthem Biosciences Statistics
Total Valuation
NSE:ANTHEM has a market cap or net worth of INR 432.97 billion. The enterprise value is 426.78 billion.
| Market Cap | 432.97B |
| Enterprise Value | 426.78B |
Important Dates
The next estimated earnings date is Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:ANTHEM has 561.61 million shares outstanding. The number of shares has decreased by -0.49% in one year.
| Current Share Class | 561.61M |
| Shares Outstanding | 561.61M |
| Shares Change (YoY) | -0.49% |
| Shares Change (QoQ) | +0.37% |
| Owned by Insiders (%) | 80.41% |
| Owned by Institutions (%) | 6.10% |
| Float | 61.92M |
Valuation Ratios
The trailing PE ratio is 85.77 and the forward PE ratio is 69.54. NSE:ANTHEM's PEG ratio is 2.67.
| PE Ratio | 85.77 |
| Forward PE | 69.54 |
| PS Ratio | 21.10 |
| PB Ratio | 17.97 |
| P/TBV Ratio | 18.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 2.67 |
Enterprise Valuation
| EV / Earnings | 84.57 |
| EV / Sales | 20.80 |
| EV / EBITDA | 57.51 |
| EV / EBIT | 65.58 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.15 |
| Debt / FCF | n/a |
| Interest Coverage | 82.16 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 17.36% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 10.45M |
| Profits Per Employee | 2.57M |
| Employee Count | 1,825 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:ANTHEM has paid 2.20 billion in taxes.
| Income Tax | 2.20B |
| Effective Tax Rate | 30.40% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 796.75 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 38.85 |
| Average Volume (20 Days) | 470,194 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ANTHEM had revenue of INR 20.52 billion and earned 5.05 billion in profits. Earnings per share was 8.99.
| Revenue | 20.52B |
| Gross Profit | 11.86B |
| Operating Income | 6.51B |
| Pretax Income | 7.25B |
| Net Income | 5.05B |
| EBITDA | 7.41B |
| EBIT | 6.51B |
| Earnings Per Share (EPS) | 8.99 |
Balance Sheet
The company has 7.32 billion in cash and 1.13 billion in debt, giving a net cash position of 6.19 billion or 11.02 per share.
| Cash & Cash Equivalents | 7.32B |
| Total Debt | 1.13B |
| Net Cash | 6.19B |
| Net Cash Per Share | 11.02 |
| Equity (Book Value) | 24.10B |
| Book Value Per Share | 43.10 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 57.81%, with operating and profit margins of 31.72% and 24.59%.
| Gross Margin | 57.81% |
| Operating Margin | 31.72% |
| Pretax Margin | 35.34% |
| Profit Margin | 24.59% |
| EBITDA Margin | 36.09% |
| EBIT Margin | 31.72% |
| FCF Margin | n/a |
Dividends & Yields
NSE:ANTHEM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.49% |
| Shareholder Yield | n/a |
| Earnings Yield | 1.17% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |